Urinary N1,N12-diacetylspermine as a biomarker for pediatric cancer: a case?control study
Urinary N1,N12-diacetylspermine as a biomarker for pediatric cancer: a case?control study
复制标题
尿 N1,N12-二乙酰精胺作为儿科癌症生物标志物:病例对照研究
DOI:
10.1007/s00383-021-04987-y
复制
发表时间:
2021
影响因子:
1.8
通讯作者:
Kawakita Masao
中科院分区:
文献类型:
--
作者:
Yokota Kazuki;Hinoki Akinari;Hiramatsu Kyoko;Amano Hizuru;Kawamura Machiko;Kuwatsuka Yachiyo;Tainaka Takahisa;Shirota Chiyoe;Sumida Wataru;Makita Satoshi;Okamoto Masamune;Takimoto Aitaro;Yasui Akihiro;Nakagawa Yoichi;Uchida Hiroo;Kawakita Masao
PurposeMinimally invasive examinations are particularly important in pediatric patients. Although the significance of urinary N1,N12-diacetylspermine (DiAcSpm) as a tumor marker (TM) has been reported in many types of adult cancers, its usefulness in pediatric cancers has not been reported. This may be due to urinary DiAcSpm level variations with age. This study aims to measure the normal levels of urinary DiAcSpm in healthy individuals and investigate its usefulness as a TM in childhood cancer.MethodsUrinary samples were collected from pediatric patients with and without cancer. The urinary DiAcSpm levels were measured, and the values were compared.ResultsA total of 32 patients with cancer and 405 controls were enrolled in the study. Of the 32 patients, 13 had neuroblastoma, 9 had malignant lymphoma (ML), and 10 had leukemia. In the control group, the urinary DiAcSpm values markedly fluctuated among those with young age, especially infants; meanwhile, the values converged among those aged roughly 10 years and above. The sensitivity of DiAcSpm was significantly different among the three types of cancers: neuroblastoma (30.8%), ML (77.8%), and leukemia (40%).ConclusionThe urinary DiAcSpm value is a useful TM for both screening and follow-up of ML.